Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Andere Sprachen
    MOR   DE0006632003   663200

MORPHOSYS AG

(663200)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über MORPHOSYS AG
22.10.European ADRs Move Higher in Friday Trading
22.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
22.10.MORPHOSYS AG : First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with ..
22.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
21.10.European ADRs Move Lower in Thursday Trading
21.10.MORPHOSYS AG : Release according to -3-
21.10.MORPHOSYS AG : Release according to -2-
20.10.MORPHOSYS : First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Imm..
20.10.MORPHOSYS AG : First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with ..
20.10.PRESS RELEASE : MorphoSys AG: First Patient Dosed -2-
20.10.PRESS RELEASE : MorphoSys AG: First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in..
20.10.MorphoSys AG Announces First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Pat..
20.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
19.10.European ADRs 0.6% Higher Tuesday Morning
18.10.European ADRs Move Lower in Monday Trading
18.10.MORPHOSYS AG : Release according to -2-
18.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
18.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
15.10.European ADRs Move Higher in Friday Trading
14.10.European ADRs Climb Higher in Thursday Trading
13.10.European ADRs Move Higher in Wednesday Trading
13.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
12.10.MORPHOSYS' : Licensing Partner Roche Received Breakthrough Therapy Designation for Gantene..
11.10.European ADRs Move Higher in Monday Trading
11.10.MORPHOSYS' : Licensing Partner Roche Received Breakthrough Therapy Designation for Gantene..
11.10.MORPHOSYS' : Licensing Partner Roche Received Breakthrough Therapy Designation for Gantene..
11.10.PRESS RELEASE : MorphoSys' Licensing Partner Roche Received Breakthrough Therapy Designati..
07.10.European ADRs Climb Higher in Thursday Trading
04.10.MORPHOSYS : Notification of managers' transactions according to article 19 MAR (Form 6-K)
04.10.European ADRs Move Lower in Monday Trading
04.10.MorphoSys AG english
04.10.MORPHOSYS AG : Release according to -2-
04.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
04.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
01.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
01.10.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
29.09.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
29.09.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
27.09.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
27.09.MORPHOSYS AG : Release according to -3-
27.09.MORPHOSYS AG : Release according to -2-
27.09.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
27.09.AVIS D'ANALYSTES DU JOUR : Valeo, Cellnex, Adyen, Drufry, Securitas, Traton, Volkswagen, H..
27.09.¿Power Crunch?
27.09.Power Crunch ?
24.09.European ADRs Move Lower in Friday Trading
23.09.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
23.09.MORPHOSYS AG : Release according to -3-
23.09.MORPHOSYS AG : Release according to -2-
23.09.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
20.09.European ADRs Move Sharply Lower in Monday Trading
20.09.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
20.09.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
20.09.MORPHOSYS AG(XTRA : MOR) added to Germany SDAX (Total Return) Index
17.09.European ADRs Down Nearly 2% Friday as Mining, Steel Shares Drop
17.09.MORPHOSYS AG(XTRA : MOR) dropped from Germany MDAX Index (Performance)
15.09.European ADRs Modestly Higher Wednesday as Energy Stocks Rally
13.09.Los mercados se quedan sin combustible
13.09.Des marchés en panne de carburant
13.09.AVIS D'ANALYSTES DU JOUR : BMW, Allianz, Getlink, Ubisoft, Neoen, Polypeptide, Verbund...
10.09.European ADRs Move Higher in Friday Trading
08.09.European ADRs Move Lower in Wednesday Trading
07.09.European ADRs Move Lower in Tuesday Trading
01.09.European ADRs Move Higher in Wednesday Trading
01.09.El apoyo, cuando nos retienen
31.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
31.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
30.08.European ADRs Move Slightly Higher in Monday Trading
27.08.MORPHOSYS : The decision by the European Commission is based on data from the L-MIND study..
27.08.INCYTE : et MorphoSys annoncent l'approbation par la Commission européenne de Minjuvi® (ta..
27.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
27.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
26.08.INCYTE : MorphoSys Treatment for Large B-Cell Lymphoma Gets Conditional Marketing Authoriz..
26.08.MORPHOSYS : and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitama..
26.08.MORPHOSYS : and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitama..
1  2  3  4  5  6  7  8  9  10Weiter
Anstehende Termine für MORPHOSYS AG